Top Midday Gainers

MT Newswires Live

Mar 17

CytomX Therapeutics (CTMX) said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.

Shares jumped roughly 63% as intraday trading volume climbed to more than 101.8 million from a daily average of about 3.3 million.

Opal Fuels (OPAL) is trading more than 18% higher after the company reported a year-over-year increase in Q4 revenue. Intraday trading volume surged to over 685,000 shares from a daily average of about 275,000.

RF Industries (RFIL) shares were up 17% ahead of the company's fiscal Q1 results anticipated Monday.

Intraday trading volume rose to over 587,000 from a daily average of roughly 214,000.

Price: 7.61, Change: +2.93, Percent Change: +62.50

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2620749371"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2620749371\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2620749371?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-17 02:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2620749371","market":"hk","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/CTMX\">CytomX</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (CTMX) said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.</p><p>Shares jumped roughly 63% as intraday trading volume climbed to more than 101.8 million from a daily average of about 3.3 million.</p><p>Opal Fuels (OPAL) is trading more than 18% higher after the company reported a year-over-year increase in Q4 revenue. Intraday trading volume surged to over 685,000 shares from a daily average of about 275,000.</p><p><a href=\"https://laohu8.com/S/RFIL\">RF Industries</a> (RFIL) shares were up 17% ahead of the company's fiscal Q1 results anticipated Monday.</p><p>Intraday trading volume rose to over 587,000 from a daily average of roughly 214,000.</p><p>Price: 7.61, Change: +2.93, Percent Change: +62.50</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-17 02:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/CTMX\">CytomX</a> <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (CTMX) said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.</p><p>Shares jumped roughly 63% as intraday trading volume climbed to more than 101.8 million from a daily average of about 3.3 million.</p><p>Opal Fuels (OPAL) is trading more than 18% higher after the company reported a year-over-year increase in Q4 revenue. Intraday trading volume surged to over 685,000 shares from a daily average of about 275,000.</p><p><a href=\"https://laohu8.com/S/RFIL\">RF Industries</a> (RFIL) shares were up 17% ahead of the company's fiscal Q1 results anticipated Monday.</p><p>Intraday trading volume rose to over 587,000 from a daily average of roughly 214,000.</p><p>Price: 7.61, Change: +2.93, Percent Change: +62.50</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTMX","symbol_name":"CytomX","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2620749371","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2620749371","pubTimestamp":1773685669,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"CytomX Therapeutics  said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.Shares jumped roughly 63% as intraday trading volume climbed to more than 101.8 million from a daily average of about 3.3 million.Opal Fuels  is trading more than 18% higher after the company reported a year-over-year increase in Q4 revenue. Intraday trading volume surged to over 685,000 shares from a daily average of about 275,000.RF Industries  shares were up 17% ahead of the company's fiscal Q1 results anticipated Monday.Intraday trading volume rose to over 587,000 from a daily average of roughly 214,000.Price: 7.61, Change: +2.93, Percent Change: +62.50","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CTMX":"CytomX","BK4145":"电子制造服务","RFIL":"RF Industries","BK4138":"石油与天然气的炼制和营销","OPAL":"OPAL Fuels Inc.","BK4139":"生物科技"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPAL":1,"RFIL":1,"CTMX":1},"content_text":"CytomX Therapeutics (CTMX) said a phase 1 clinical trial evaluating varsetatug masetecan in patients with advanced colorectal cancer yielded confirmed response rates of up to 32%.Shares jumped roughly 63% as intraday trading volume climbed to more than 101.8 million from a daily average of about 3.3 million.Opal Fuels (OPAL) is trading more than 18% higher after the company reported a year-over-year increase in Q4 revenue. Intraday trading volume surged to over 685,000 shares from a daily average of about 275,000.RF Industries (RFIL) shares were up 17% ahead of the company's fiscal Q1 results anticipated Monday.Intraday trading volume rose to over 587,000 from a daily average of roughly 214,000.Price: 7.61, Change: +2.93, Percent Change: +62.50","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}